marnell pharmacy ltd
marnell pharmacy ltd Company Information
Company Number
SC525301
Next Accounts
Jan 2026
Directors
Shareholders
marnell(east) ltd
peter edgley
View AllGroup Structure
View All
Industry
Other human health activities
Registered Address
c/o robb ferguson regent court, 70 west regent street, glasgow, G2 2QZ
Website
mabbott.commarnell pharmacy ltd Estimated Valuation
Pomanda estimates the enterprise value of MARNELL PHARMACY LTD at £2.1m based on a Turnover of £3.5m and 0.61x industry multiple (adjusted for size and gross margin).
marnell pharmacy ltd Estimated Valuation
Pomanda estimates the enterprise value of MARNELL PHARMACY LTD at £1.5m based on an EBITDA of £335.5k and a 4.6x industry multiple (adjusted for size and gross margin).
marnell pharmacy ltd Estimated Valuation
Pomanda estimates the enterprise value of MARNELL PHARMACY LTD at £261k based on Net Assets of £104.7k and 2.49x industry multiple (adjusted for liquidity).
Edit your figures and get a professional valuation report.
Marnell Pharmacy Ltd Overview
Marnell Pharmacy Ltd is a live company located in glasgow, G2 2QZ with a Companies House number of SC525301. It operates in the other human health activities sector, SIC Code 86900. Founded in January 2016, it's largest shareholder is marnell(east) ltd with a 70% stake. Marnell Pharmacy Ltd is a young, small sized company, Pomanda has estimated its turnover at £3.5m with healthy growth in recent years.
Upgrade for unlimited company reports & a free credit check
Marnell Pharmacy Ltd Health Check
Pomanda's financial health check has awarded Marnell Pharmacy Ltd a 3.5 rating. We use a traffic light system to show it exceeds the industry average on 5 measures and has 5 areas for improvement. Company Health Check FAQs
5 Strong
2 Regular
5 Weak
Size
annual sales of £3.5m, make it larger than the average company (£656.4k)
- Marnell Pharmacy Ltd
£656.4k - Industry AVG
Growth
3 year (CAGR) sales growth of 12%, show it is growing at a faster rate (8.1%)
- Marnell Pharmacy Ltd
8.1% - Industry AVG
Production
with a gross margin of 39%, this company has a comparable cost of product (39%)
- Marnell Pharmacy Ltd
39% - Industry AVG
Profitability
an operating margin of 4.2% make it less profitable than the average company (5.5%)
- Marnell Pharmacy Ltd
5.5% - Industry AVG
Employees
with 29 employees, this is above the industry average (17)
29 - Marnell Pharmacy Ltd
17 - Industry AVG
Pay Structure
on an average salary of £27.4k, the company has an equivalent pay structure (£27.4k)
- Marnell Pharmacy Ltd
£27.4k - Industry AVG
Efficiency
resulting in sales per employee of £119.2k, this is more efficient (£49k)
- Marnell Pharmacy Ltd
£49k - Industry AVG
Debtor Days
it gets paid by customers after 32 days, this is later than average (20 days)
- Marnell Pharmacy Ltd
20 days - Industry AVG
Creditor Days
its suppliers are paid after 74 days, this is slower than average (17 days)
- Marnell Pharmacy Ltd
17 days - Industry AVG
Stock Days
it holds stock equivalent to 34 days, this is more than average (13 days)
- Marnell Pharmacy Ltd
13 days - Industry AVG
Cash Balance
has cash to cover current liabilities for 13 weeks, this is less cash available to meet short term requirements (108 weeks)
13 weeks - Marnell Pharmacy Ltd
108 weeks - Industry AVG
Debt Level
it has a ratio of liabilities to total assets of 97%, this is a higher level of debt than the average (25.3%)
97% - Marnell Pharmacy Ltd
25.3% - Industry AVG
MARNELL PHARMACY LTD financials
Marnell Pharmacy Ltd's latest turnover from April 2024 is estimated at £3.5 million and the company has net assets of £104.7 thousand. According to their latest financial statements, Marnell Pharmacy Ltd has 29 employees and maintains cash reserves of £265.2 thousand as reported in the balance sheet.
Data source: Companies House, Pomanda Estimates
| Apr 2024 | Apr 2023 | Apr 2022 | Apr 2021 | Apr 2020 | Apr 2019 | Apr 2018 | Apr 2017 | |
|---|---|---|---|---|---|---|---|---|
| Turnover | ||||||||
| Other Income Or Grants | ||||||||
| Cost Of Sales | ||||||||
| Gross Profit | ||||||||
| Admin Expenses | ||||||||
| Operating Profit | ||||||||
| Interest Payable | ||||||||
| Interest Receivable | ||||||||
| Pre-Tax Profit | ||||||||
| Tax | ||||||||
| Profit After Tax | ||||||||
| Dividends Paid | ||||||||
| Retained Profit | ||||||||
| Employee Costs | ||||||||
| Number Of Employees | 29 | 18 | 16 | 17 | 14 | 12 | 12 | 11 |
| EBITDA* |
* Earnings Before Interest, Tax, Depreciation and Amortisation
| Apr 2024 | Apr 2023 | Apr 2022 | Apr 2021 | Apr 2020 | Apr 2019 | Apr 2018 | Apr 2017 | |
|---|---|---|---|---|---|---|---|---|
| Tangible Assets | 167,714 | 184,034 | 45,500 | 35,096 | 42,697 | 54,840 | 61,948 | 29,423 |
| Intangible Assets | 2,442,850 | 1,149,322 | 1,237,732 | 1,326,142 | 1,414,552 | 1,502,962 | 1,591,374 | 1,790,296 |
| Investments & Other | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Debtors (Due After 1 year) | 17,250 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Total Fixed Assets | 2,627,814 | 1,333,356 | 1,283,232 | 1,361,238 | 1,457,249 | 1,557,802 | 1,653,322 | 1,819,719 |
| Stock & work in progress | 200,449 | 103,304 | 123,827 | 103,838 | 99,582 | 105,747 | 113,122 | 112,055 |
| Trade Debtors | 305,961 | 217,138 | 224,556 | 267,102 | 206,564 | 174,478 | 265,870 | 266,102 |
| Group Debtors | 0 | 0 | 228,093 | 216,383 | 261,720 | 0 | 0 | 0 |
| Misc Debtors | 137,332 | 153,055 | 89,495 | 130,565 | 171,905 | 104,833 | 166,781 | 36,223 |
| Cash | 265,176 | 324,775 | 307,109 | 176,778 | 276,471 | 215,457 | 148,111 | 248,973 |
| misc current assets | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| total current assets | 908,918 | 798,272 | 973,080 | 894,666 | 1,016,242 | 600,515 | 693,884 | 663,353 |
| total assets | 3,536,732 | 2,131,628 | 2,256,312 | 2,255,904 | 2,473,491 | 2,158,317 | 2,347,206 | 2,483,072 |
| Bank overdraft | 99,895 | 55,748 | 59,417 | 60,099 | 54,826 | 54,016 | 53,513 | 52,548 |
| Bank loan | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Trade Creditors | 429,793 | 271,438 | 377,611 | 233,063 | 300,239 | 197,142 | 228,163 | 178,734 |
| Group/Directors Accounts | 366,245 | 236,146 | 452 | 0 | 0 | 0 | 0 | 22,211 |
| other short term finances | 0 | 0 | 400,000 | 145,685 | 316,850 | 0 | 0 | 60,000 |
| hp & lease commitments | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| other current liabilities | 150,281 | 106,563 | 153,484 | 184,948 | 116,451 | 194,038 | 290,488 | 185,665 |
| total current liabilities | 1,046,214 | 669,895 | 990,964 | 623,795 | 788,366 | 445,196 | 572,164 | 499,158 |
| loans | 2,352,567 | 1,268,150 | 1,120,229 | 1,508,963 | 1,608,354 | 1,698,305 | 1,762,555 | 1,765,510 |
| hp & lease commitments | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Accruals and Deferred Income | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| other liabilities | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 211,941 |
| provisions | 33,260 | 36,283 | 11,375 | 6,669 | 8,113 | 10,420 | 10,531 | 5,296 |
| total long term liabilities | 2,385,827 | 1,304,433 | 1,131,604 | 1,515,632 | 1,616,467 | 1,708,725 | 1,773,086 | 1,982,747 |
| total liabilities | 3,432,041 | 1,974,328 | 2,122,568 | 2,139,427 | 2,404,833 | 2,153,921 | 2,345,250 | 2,481,905 |
| net assets | 104,691 | 157,300 | 133,744 | 116,477 | 68,658 | 4,396 | 1,956 | 1,167 |
| total shareholders funds | 104,691 | 157,300 | 133,744 | 116,477 | 68,658 | 4,396 | 1,956 | 1,167 |
| Apr 2024 | Apr 2023 | Apr 2022 | Apr 2021 | Apr 2020 | Apr 2019 | Apr 2018 | Apr 2017 | |
|---|---|---|---|---|---|---|---|---|
| Operating Activities | ||||||||
| Operating Profit | ||||||||
| Depreciation | 36,381 | 26,732 | 10,657 | 11,272 | 14,057 | 17,506 | 17,161 | 9,808 |
| Amortisation | 154,791 | 88,410 | 88,410 | 88,410 | 88,410 | 88,412 | 198,922 | 198,922 |
| Tax | ||||||||
| Stock | 97,145 | -20,523 | 19,989 | 4,256 | -6,165 | -7,375 | 1,067 | 112,055 |
| Debtors | 90,350 | -171,951 | -71,906 | -26,139 | 360,878 | -153,340 | 130,326 | 302,325 |
| Creditors | 158,355 | -106,173 | 144,548 | -67,176 | 103,097 | -31,021 | 49,429 | 178,734 |
| Accruals and Deferred Income | 43,718 | -46,921 | -31,464 | 68,497 | -77,587 | -96,450 | 104,823 | 185,665 |
| Deferred Taxes & Provisions | -3,023 | 24,908 | 4,706 | -1,444 | -2,307 | -111 | 5,235 | 5,296 |
| Cash flow from operations | ||||||||
| Investing Activities | ||||||||
| capital expenditure | ||||||||
| Change in Investments | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| cash flow from investments | ||||||||
| Financing Activities | ||||||||
| Bank loans | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Group/Directors Accounts | 130,099 | 235,694 | 452 | 0 | 0 | 0 | -22,211 | 22,211 |
| Other Short Term Loans | 0 | -400,000 | 254,315 | -171,165 | 316,850 | 0 | -60,000 | 60,000 |
| Long term loans | 1,084,417 | 147,921 | -388,734 | -99,391 | -89,951 | -64,250 | -2,955 | 1,765,510 |
| Hire Purchase and Lease Commitments | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| other long term liabilities | 0 | 0 | 0 | 0 | 0 | 0 | -211,941 | 211,941 |
| share issue | ||||||||
| interest | ||||||||
| cash flow from financing | ||||||||
| cash and cash equivalents | ||||||||
| cash | -59,599 | 17,666 | 130,331 | -99,693 | 61,014 | 67,346 | -100,862 | 248,973 |
| overdraft | 44,147 | -3,669 | -682 | 5,273 | 810 | 503 | 965 | 52,548 |
| change in cash | -103,746 | 21,335 | 131,013 | -104,966 | 60,204 | 66,843 | -101,827 | 196,425 |
marnell pharmacy ltd Credit Report and Business Information
Marnell Pharmacy Ltd Competitor Analysis
Perform a competitor analysis for marnell pharmacy ltd by selecting its closest rivals, whether from the HUMAN HEALTH AND SOCIAL WORK ACTIVITIES sector, other small companies, companies in G 2 area or any other competitors across 12 key performance metrics.
marnell pharmacy ltd Ownership
MARNELL PHARMACY LTD group structure
Marnell Pharmacy Ltd has no subsidiary companies.
marnell pharmacy ltd directors
Marnell Pharmacy Ltd currently has 1 director, Mr Shaun Marnell serving since Jan 2016.
| officer | country | age | start | end | role |
|---|---|---|---|---|---|
| Mr Shaun Marnell | 42 years | Jan 2016 | - | Director |
P&L
April 2024turnover
3.5m
+71%
operating profit
144.3k
0%
gross margin
39%
+2.09%
turnover
Turnover, or revenue, is the amount of sales generated by a company within the financial year.
Balance Sheet
April 2024net assets
104.7k
-0.33%
total assets
3.5m
+0.66%
cash
265.2k
-0.18%
net assets
Total assets minus all liabilities
marnell pharmacy ltd company details
company number
SC525301
Type
Private limited with Share Capital
industry
86900 - Other human health activities
incorporation date
January 2016
age
9
incorporated
UK
ultimate parent company
accounts
Total Exemption Full
last accounts submitted
April 2024
previous names
N/A
accountant
ROBB FERGUSON CHARTERED ACCOUNTANTS
auditor
-
address
c/o robb ferguson regent court, 70 west regent street, glasgow, G2 2QZ
Bank
-
Legal Advisor
-
marnell pharmacy ltd Charges & Mortgages
A charge, or mortgage, refers to the rights a company gives to a lender in return for a loan, often in the form of security given over business assets.
We did not find charges/mortgages relating to marnell pharmacy ltd.
marnell pharmacy ltd Capital Raised & Share Issues BETA
When a company issues new shares, e.g. to new investors following a funding round, it is required to notify Companies House within one month of making an allotment of shares.
Click to start generating capital raising & share issue transactions for MARNELL PHARMACY LTD. This can take several minutes, an email will notify you when this has completed.
marnell pharmacy ltd Companies House Filings - See Documents
| date | description | view/download |
|---|
